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Aims
The aim of the present study was to investigate whether
tumour cell supernatants of 4 different malignant tumour
cell lines with different aggressive behaviour show compa-
rable pathobiological reactions.
Methods
Mature mouse (C57/Bl6) macrophages were incubated
with the a.m. different tumour cell supernatants and fol-
lowed by the investigation of apoptosis factors using
immunocytochemistry. In addition, the experiments were
performed with Fas-knock-out mouse macrophages and
PCR in order to investigate the involvement of the Fas/
FasL system.
Results
All tumour cell supernatants investigated induced a signif-
icant increase of apoptototic activities in macrophages
compared with control groups. Interestingly, the tumour
cell supernatants showed differences in their intensities of
apoptosis-inducing effects on the macrophages one to
each other. The Fas/FasL system has been identified as one
of the involved factors from tumours which induce apo-
toses in macrophages.
Conclusion
Our observation of the induction of apoptoses in macro-
phages due to so far undefined tumour cell factors sup-
ports the counterattack hypothesis which supposes the
active destruction of the tumoricidal cell system by neo-
plastic cells. For now, the counterattack is an exciting new
way for research in tumour immunology and probably
offers a therapeutic potential.
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